Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/17/2025

Clinical Presentation and Diagnosis of Wolff-Parkinson-White Syndrome

Introduction to Wolff-Parkinson-White Syndrome

  • The European Society of Cardiology notes that Wolff-Parkinson-White syndrome presents with characteristic ECG findings of ventricular pre-excitation, and may be either asymptomatic or symptomatic with tachyarrhythmias, palpitations, syncope, or in rare cases, sudden cardiac death 1

Electrocardiographic Features

  • The American Heart Association recommends that the ECG diagnosis of Wolff-Parkinson-White syndrome requires all of the following features present simultaneously: delta wave, PR interval <0.12 seconds, and QRS complex widening >0.12 seconds, with the European Heart Journal citing this as the defining feature 1, 2

Clinical Presentations

  • Approximately 50% of patients with the WPW ECG pattern remain asymptomatic throughout their lives, discovered incidentally on routine ECG or during pre-participation sports screening, according to the European Heart Journal and Circulation 1, 3
  • The prevalence of asymptomatic WPW pattern is 0.1-0.3% in the general population, as noted by the European Heart Journal 1

Arrhythmic Manifestations

  • The European Heart Journal states that pre-excited atrial fibrillation is the most dangerous arrhythmia, occurring in 0-9% of asymptomatic patients and up to one-third of all WPW patients, characterized by wide QRS complexes with irregular rhythm 1, 2
  • Ventricular fibrillation occurs in 0-2% of asymptomatic patients when atrial fibrillation degenerates due to very rapid ventricular rates via the accessory pathway, as cited by the European Heart Journal and Praxis Medical Insights 1, 2

High-Risk Features Predicting Sudden Death

  • The European Heart Journal and Praxis Medical Insights identify the shortest pre-excited RR interval <250 ms during atrial fibrillation as the strongest predictor of sudden cardiac death risk 1, 2, 4
  • A history of symptomatic tachycardia increases sudden death risk, with symptomatic patients having 2.2% annual risk versus 0.15-0.2% in asymptomatic patients, according to the European Heart Journal and Praxis Medical Insights 1, 4

Low-Risk Indicators

  • The European Heart Journal notes that intermittent pre-excitation on resting ECG or ambulatory monitoring indicates low risk with 90% positive predictive value 1, 2
  • Abrupt loss of pre-excitation during exercise testing suggests long accessory pathway refractory period and low sudden death risk, as cited by the European Heart Journal and Praxis Medical Insights 1, 2

Associated Structural Heart Disease

  • Most patients (93-95%) have structurally normal hearts, according to Circulation 3

Special Population Considerations

  • Ventricular fibrillation occurs predominantly in children (0-2% of asymptomatic patients), as noted by Praxis Medical Insights 2
  • Higher risk of sudden death in the first two decades of life, according to Praxis Medical Insights 2